Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Diagnostic Value of the Self-report T-ACE for Screening of High-risk Alcohol Consumption During Pregnancy : Comparison With the Dosage of a Blood Biomarker Used as Gold Standard. AUTOQUEST Study.

NCT04786587 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04786587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04786587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Diagnostic Value of the Self-report T-ACE for Screening of High-risk Alcohol Consumption During Pregnancy : Comparison With the Dosage of a Blood Biomarker Used as Gold Standard. AUTOQUEST Study.
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Recruiting
Start date
April 8, 2024
Completion date
April 30, 2027
Enrollment
2,425 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, pregnancy